国产bbaaaaa片,成年美女黄网站色视频免费,成年黄大片,а天堂中文最新一区二区三区,成人精品视频一区二区三区尤物

首頁(yè)> 美國(guó)政府科技報(bào)告 >Myeloid-Biased Stem Cells as Potential Targets for Chronic Myelogeneous Leukemia
【24h】

Myeloid-Biased Stem Cells as Potential Targets for Chronic Myelogeneous Leukemia

機(jī)譯:骨髓偏向的干細(xì)胞是慢性粒細(xì)胞白血病的潛在靶點(diǎn)

獲取原文

摘要

CML results from the malignant transformation of a pluripotent hematopoletic stem cell (HSC). We identified novel subsets of HSC, called Myeloid-biased (My-bi) HSC. These HSC are epigenetically programmed to generate progeny that is skewed towards the myeloid lineage. Thus, both the normal My-bi HSC and the transformed CML HSC generate a myeloidbiased progeny. Accordingly, we hypothesized that My-bi HSC are the target of transformation that can lead to CML. We are taking advantage of a mouse model for CML. We will isolate the different types of HSC that we have identified and will infect these with replication deficient retroviri containing the myeloid-associated p2lO form of the Bcr/Abl construct. If our hypothesis is correct, My-bi HSC, but not balanced or Ly-bi, HSC can be transformed to give rise to myelogenous leukemia. We have begun to generate clonally repopulated host animals and have identified linage biased HSC. We have also begun a series of experiments to define the conditions that will yield high titer retrovirus for the proposed studies. The proposed studies for the first time raise the possibility to selectively target My-bi HSC for therapy. This would leave other HSC untouched, limiting the toxicity of therapy.

著錄項(xiàng)

相似文獻(xiàn)

  • 外文文獻(xiàn)
  • 中文文獻(xiàn)
  • 專利
獲取原文

客服郵箱:kefu@zhangqiaokeyan.com

京公網(wǎng)安備:11010802029741號(hào) ICP備案號(hào):京ICP備15016152號(hào)-6 六維聯(lián)合信息科技 (北京) 有限公司?版權(quán)所有
  • 客服微信

  • 服務(wù)號(hào)